Decoy Therapeutics Inc. Operating Cash Flow
Decoy Therapeutics Inc. (DCOY) reported Operating Cash Flow of -$5.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.65M.
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.89M.
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.14M.
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.65M.
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$4.83M.
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$4.53M.
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$12.85M.
- Decoy Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$17.60M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 4 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$5.54M 10-Q · filed 2026-08-12 | -$6.68M derived: sum of 3 quarters · filed 2026-08-12 | -$8.32M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2026-03-31 | -$2.89M 10-Q · filed 2026-05-08 | -$4.03M derived: sum of 2 quarters · filed 2026-05-08 | -$5.67M derived: sum of 3 quarters · filed 2026-05-08 | -$6.53M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.78M derived: sum of 2 quarters · filed 2026-03-31 | -$3.65M derived: sum of 3 quarters · filed 2026-08-12 | -$4.83M 10-K · filed 2026-03-31 | ||||||||
| 2025-09-30 | -$1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.51M derived: sum of 2 quarters · filed 2026-08-12 | -$3.69M 10-Q · filed 2025-11-14 | -$4.43M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-06-30 | -$862.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.04M 10-Q · filed 2026-08-12 | -$2.79M derived: sum of 3 quarters · filed 2026-08-12 | -$4.14M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-03-31 | -$1.18M 10-Q · filed 2026-05-08 | -$1.92M derived: sum of 2 quarters · filed 2026-05-08 | -$3.28M derived: sum of 3 quarters · filed 2026-05-08 | -$4.35M derived: sum of 4 quarters · filed 2026-05-08 | ||||||||
| 2024-12-31 | -$742.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.10M derived: sum of 2 quarters · filed 2026-03-31 | -$3.17M derived: sum of 3 quarters · filed 2026-03-31 | -$4.53M 10-K · filed 2026-03-31 | ||||||||
| 2024-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.43M derived: sum of 2 quarters · filed 2025-11-14 | -$3.78M 10-Q · filed 2025-11-14 | -$5.29M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.43M 10-Q · filed 2025-08-12 | -$3.94M derived: sum of 3 quarters · filed 2025-08-12 | -$7.69M derived: sum of 4 quarters · filed 2025-08-12 | ||||||||
| 2024-03-31 | -$1.35M 10-Q · filed 2025-05-14 | -$2.87M derived: sum of 2 quarters · filed 2025-05-14 | -$6.61M derived: sum of 3 quarters · filed 2025-05-14 | -$11.03M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2023-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$5.26M derived: sum of 2 quarters · filed 2025-03-21 | -$9.68M derived: sum of 3 quarters · filed 2025-03-21 | -$12.85M 10-K · filed 2025-03-21 | ||||||||
| 2023-09-30 | -$3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$8.17M derived: sum of 2 quarters · filed 2024-11-14 | -$11.33M 10-Q · filed 2024-11-14 | -$16.05M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||
| 2023-06-30 | -$4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$7.59M 10-Q · filed 2024-08-09 | -$12.30M derived: sum of 3 quarters · filed 2024-08-09 | -$18.04M derived: sum of 4 quarters · filed 2024-08-09 | ||||||||
| 2023-03-31 | -$3.17M 10-Q · filed 2024-05-13 | -$7.88M derived: sum of 2 quarters · filed 2024-05-13 | -$13.62M derived: sum of 3 quarters · filed 2024-05-13 | -$17.24M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2022-12-31 | -$4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$10.45M derived: sum of 2 quarters · filed 2024-03-22 | -$14.07M derived: sum of 3 quarters · filed 2024-03-22 | -$17.60M 10-K · filed 2024-03-22 | ||||||||
| 2022-09-30 | -$5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$9.36M derived: sum of 2 quarters · filed 2023-11-09 | -$12.88M 10-Q · filed 2023-11-09 | -$15.60M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||
| 2022-06-30 | -$3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$7.14M 10-Q · filed 2023-08-10 | -$9.86M derived: sum of 3 quarters · filed 2023-08-10 | -$11.44M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | -$3.52M 10-Q · filed 2023-05-11 | -$6.24M derived: sum of 2 quarters · filed 2023-05-11 | -$7.82M derived: sum of 3 quarters · filed 2023-05-11 | -$11.00M derived: sum of 4 quarters · filed 2023-05-11 | ||||||||
| 2021-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$4.30M derived: sum of 2 quarters · filed 2023-03-27 | -$7.48M derived: sum of 3 quarters · filed 2023-03-27 | -$10.20M 10-K · filed 2023-03-27 | ||||||||
| 2021-09-30 | -$1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$4.76M derived: sum of 2 quarters · filed 2022-11-10 | -$7.48M 10-Q · filed 2022-11-10 | -$8.85M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||
| 2021-06-30 | -$3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$5.90M 10-Q · filed 2022-08-05 | -$7.27M derived: sum of 3 quarters · filed 2022-08-05 | -$10.02M derived: sum of 4 quarters · filed 2022-08-05 | ||||||||
| 2021-03-31 | -$2.72M 10-Q · filed 2022-05-12 | -$4.10M derived: sum of 2 quarters · filed 2022-05-12 | -$6.85M derived: sum of 3 quarters · filed 2022-05-12 | -$9.33M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$4.13M derived: sum of 2 quarters · filed 2022-03-25 | -$6.60M derived: sum of 3 quarters · filed 2022-03-25 | -$10.31M 10-K · filed 2022-03-25 | ||||||||
| 2020-09-30 | -$2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$5.23M derived: sum of 2 quarters · filed 2021-11-04 | -$8.94M 10-Q · filed 2021-11-04 | -$11.57M derived: sum of 4 quarters · filed 2021-11-04 | ||||||||
| 2020-06-30 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$6.18M 10-Q · filed 2021-08-05 | -$8.82M derived: sum of 3 quarters · filed 2021-08-05 | -$14.36M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||
| 2020-03-31 | -$3.71M 10-Q · filed 2021-05-12 | -$6.34M derived: sum of 2 quarters · filed 2021-05-12 | -$11.89M derived: sum of 3 quarters · filed 2021-05-12 | -$13.42M derived: sum of 4 quarters · filed 2021-05-12 | ||||||||
| 2019-12-31 | -$2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$8.18M derived: sum of 2 quarters · filed 2021-03-18 | -$9.71M derived: sum of 3 quarters · filed 2021-03-18 | -$11.58M 10-K · filed 2021-03-18 | ||||||||
| 2019-09-30 | -$5.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$7.07M derived: sum of 2 quarters · filed 2020-11-12 | -$8.94M 10-Q · filed 2020-11-12 | -$8.56M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||
| 2019-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-08-12 | -$3.40M 10-Q · filed 2020-08-12 | -$3.44M 10-Q · filed 2019-07-17 | -$3.01M derived: sum of 3 quarters · filed 2020-08-12 | $18.44M derived: sum of 4 quarters · filed 2020-08-12 | |||||||
| 2019-03-31 | -$1.87M 10-Q/A · filed 2020-05-15 | -$2.66M 10-Q · filed 2019-05-01 | -$1.48M derived: sum of 2 quarters · filed 2020-05-15 | $19.98M derived: sum of 3 quarters · filed 2020-05-15 | $11.72M derived: sum of 4 quarters · filed 2020-05-15 | |||||||
| 2018-12-31 | $387.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $21.85M derived: sum of 2 quarters · filed 2020-03-23 | $13.59M derived: sum of 3 quarters · filed 2020-03-23 | $4.18M 10-K · filed 2020-03-23 | -$23.60M 10-K · filed 2019-03-06 | |||||||
| 2018-09-30 | $21.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $13.20M derived: sum of 2 quarters · filed 2019-11-12 | $3.79M 10-Q · filed 2019-11-12 | -$20.46M 10-Q · filed 2018-11-05 | -$1.97M derived: sum of 4 quarters · filed 2019-11-12 | |||||||
| 2018-06-30 | -$8.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-17 | -$17.67M 10-Q · filed 2019-07-17 | -$23.42M derived: sum of 3 quarters · filed 2019-07-17 | -$31.47M derived: sum of 4 quarters · filed 2019-07-17 | ||||||||
| 2018-03-31 | -$9.41M 10-Q · filed 2019-05-01 | -$15.17M derived: sum of 2 quarters · filed 2019-05-01 | -$23.22M derived: sum of 3 quarters · filed 2019-05-01 | -$28.91M derived: sum of 4 quarters · filed 2019-05-01 | ||||||||
| 2017-12-31 | -$5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$13.81M derived: sum of 2 quarters · filed 2019-03-06 | -$19.50M derived: sum of 3 quarters · filed 2019-03-06 | -$27.72M 10-K · filed 2019-03-06 | ||||||||
| 2017-09-30 | -$8.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$13.74M derived: sum of 2 quarters · filed 2018-11-05 | -$21.97M 10-Q · filed 2018-11-05 | -$22.09M 10-Q · filed 2017-11-06 | -$28.27M derived: sum of 4 quarters · filed 2019-03-06 | |||||||
| 2017-06-30 | -$5.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$13.92M 10-Q · filed 2018-08-01 | -$20.21M derived: sum of 3 quarters · filed 2019-03-06 | -$27.47M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2017-03-31 | -$8.23M 10-Q · filed 2018-05-02 | -$14.52M derived: sum of 2 quarters · filed 2019-03-06 | -$21.78M derived: sum of 3 quarters · filed 2019-03-06 | -$31.10M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2016-12-31 | -$6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$13.55M derived: sum of 2 quarters · filed 2019-03-06 | -$22.88M derived: sum of 3 quarters · filed 2019-03-06 | -$32.05M 10-K · filed 2019-03-06 | -$32.05M 10-K · filed 2017-03-08 | |||||||
| 2016-09-30 | -$7.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$16.58M derived: sum of 2 quarters · filed 2017-11-06 | -$25.75M 10-Q · filed 2017-11-06 | -$31.19M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-06-30 | -$9.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$18.50M 10-Q · filed 2017-08-02 | -$23.94M derived: sum of 3 quarters · filed 2018-03-07 | -$30.64M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-03-31 | -$9.17M 10-Q · filed 2017-05-03 | -$14.61M derived: sum of 2 quarters · filed 2018-03-07 | -$21.31M derived: sum of 3 quarters · filed 2018-03-07 | -$25.78M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2015-12-31 | -$5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$12.14M derived: sum of 2 quarters · filed 2018-03-07 | -$16.61M derived: sum of 3 quarters · filed 2018-03-07 | -$20.75M 10-K · filed 2018-03-07 | ||||||||
| 2015-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$11.17M derived: sum of 2 quarters · filed 2016-11-02 | -$15.31M 10-Q · filed 2016-11-02 | |||||||||
| 2015-06-30 | -$4.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$8.61M 10-Q · filed 2016-08-03 | ||||||||||
| 2015-03-31 | -$4.14M 10-Q · filed 2016-05-04 | |||||||||||
| 2014-12-31 | -$6.48M 10-K · filed 2017-03-08 | |||||||||||
| 2014-06-30 | -$3.17M 10-Q · filed 2015-11-04 | -$1.26M 10-Q · filed 2015-08-05 | ||||||||||
| 2014-03-31 | $74.30K 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |